JP Morgan Chase’s BioLife Solutions BLFS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.37M Sell
232,694
-10,866
-4% -$240K ﹤0.01% 3446
2025
Q4
$5.89M Buy
243,560
+17,946
+8% +$470K ﹤0.01% 3156
2025
Q3
$5.76M Sell
225,614
-5,984
-3% -$142K ﹤0.01% 3229
2025
Q2
$4.99M Sell
231,598
-11,680
-5% -$263K ﹤0.01% 3175
2025
Q1
$5.56M Sell
243,278
-10,307
-4% -$271K ﹤0.01% 3059
2024
Q4
$6.58M Sell
253,585
-24,748
-9% -$616K ﹤0.01% 3098
2024
Q3
$6.97M Sell
278,333
-7,402
-3% -$175K ﹤0.01% 2939
2024
Q2
$6.12M Sell
285,735
-49,213
-15% -$955K ﹤0.01% 2879
2024
Q1
$6.21M Sell
334,948
-19,852
-6% -$347K ﹤0.01% 2906
2023
Q4
$5.77M Sell
354,800
-19,541
-5% -$249K ﹤0.01% 2962
2023
Q3
$5.17M Sell
374,341
-28,896
-7% -$455K ﹤0.01% 2824
2023
Q2
$8.91M Sell
403,237
-2,031
-0.5% -$42.8K ﹤0.01% 2385
2023
Q1
$8.81M Buy
405,268
+1,250
+0.3% +$28.1K ﹤0.01% 2386
2022
Q4
$7.35M Sell
404,018
-1,652
-0.4% -$34.1K ﹤0.01% 2522
2022
Q3
$9.23M Sell
405,670
-49,179
-11% -$1.05M ﹤0.01% 2207
2022
Q2
$6.28M Buy
454,849
+15,397
+4% +$226K ﹤0.01% 2570
2022
Q1
$9.99M Sell
439,452
-32,123
-7% -$846K ﹤0.01% 2372
2021
Q4
$17.6M Buy
471,575
+81,435
+21% +$3.49M ﹤0.01% 1922
2021
Q3
$16.5M Sell
390,140
-115,546
-23% -$5.56M ﹤0.01% 1925
2021
Q2
$22.5M Buy
505,686
+156,325
+45% +$5.51M ﹤0.01% 1738
2021
Q1
$12.6M Buy
349,361
+126,840
+57% +$5.02M ﹤0.01% 2148
2020
Q4
$8.88M Buy
222,521
+103,276
+87% +$3.52M ﹤0.01% 2306
2020
Q3
$3.42M Buy
119,245
+46,474
+64% +$1M ﹤0.01% 2858
2020
Q2
$1.19M Buy
72,771
+29,586
+69% +$408K ﹤0.01% 3412
2020
Q1
$410K Buy
43,185
+25,494
+144% +$350K ﹤0.01% 3918
2019
Q4
$286K Buy
17,691
+15,479
+700% +$252K ﹤0.01% 4533
2019
Q3
$37K Buy
2,212
+379
+21% +$7.11K ﹤0.01% 5265
2019
Q2
$30K Buy
+1,833
New +$32K ﹤0.01% 5350

Other funds holding BLFS